| View |
2019-08-08-0184
|
Meningococcal Polysaccharide Serogroups A, C, W-135 and Y Conjugate Vaccine
|
Nimenrix
|
BR-924
|
AMECA091A
|
Packaging Lot: A90CA356A, 12,630 doses/boxes
Vial: A90FA356A, Diluent: A90DA356A, MD 10-2017, ED 09-2022
Needle (25G x 1") - 1807029 (ED: 2023-06-30),
Needle (23G x 1") - 1805011 (ED: 2023-05-31)
Packaging Lot: A90CA357A, 10,050 doses/boxes
Vial: A90FA357A, Diluent: A90DA357A, MD 02-2018, ED 01-2023
Needle (25G x 1") - 1811031 (ED: 2023-10-31),
Needle (23G x 1") - 1810032 (ED: 2023-09-30)
Packaging Lot: A90CA314A; vial - A90FA314A; Diluent – A90DA314A (MD: 04-2016; ED: 03-2021); Needle (25G x 1") - 1704028 (ED: 2022-04-30), Needle (23G x 1") - 1702011 (ED: 2022-02-28)
|
31 March 2021
|
20 September 2019
|
| View |
2019-10-08-0259
|
Diphtheria, Tetanus, Pertussis (Acellular Component), Hepatitis B, Poliomyelitis (Inactivated) and Haemophilus influenzae Type B Conjugate Vaccine (Adsorbed) [DTap-IPV-HepB-Hib]
|
Hexaxim
|
BR-919
|
R3F98
|
Packaging lot: R3F981V
Pre-filled syringe: R3F98
Needle 25G x 5/8": 1905025
Needle 23G x 1": 1905001
|
31 March 2021
|
11 October 2019
|
| View |
2019-11-13-0279
|
Inactivated Rabies Vaccine (Wistar Strain Rabies)
|
Verorab
|
BR-514
|
R1B99
|
Packaging Lot: Box - R1B992V; Vials - R1B99;
Ampoule (diluent) - R4A03 (ED: 03-2021)
|
31 March 2021
|
15 November 2019
|
| View |
2020-01-24-0020
|
BCG Vaccine
|
-
|
BR-457
|
1659
|
Packaging Lot:
Box and vaccine ampoule: 1659;
Diluent ampoule: I-1558
|
31 March 2021
|
28 January 2020
|
| View |
2019-04-17-0083
|
Pneumococcal Polysaccharide and Non-Typeable Haemophilus Influenzae (NTHi) Protein D Conjugate Vaccine, Adsorbed
|
Synflorix
|
BR-685
|
ASPNB201D
|
Packaging Lot: Box & PFS - ASPNB201DE; Needle (25G x 1") - 1810007 (ED: 2023-09-30)
|
31 March 2022
|
24 April 2019
|
| View |
2019-12-10-0302
|
Diphtheria-Tetanus Toxoids and Acellular Pertussis Vaccine
|
Boostrix
|
BR-630
|
AC37B355C
|
Packaging Lot (Box): AC37B355CE;
PFS: AC37B355CE; ED: 03-2022;
Needle 23G x 1" Lot: 1903015, ED: 2024-02-29;
Needle 25G x 5/8" Lot: 1904026, ED: 2024-03-31
|
31 March 2022
|
12 December 2019
|
| View |
2019-12-17-0309
|
Tetanus Toxoid
|
Bio-TT
|
BR-663
|
280919
|
Packaging Lot (box and ampoule): 0280919
|
31 March 2022
|
20 December 2019
|
| View |
2019-12-17-0310
|
Tetanus Toxoid
|
Bio-TT
|
BR-663
|
280719
|
Packaging Lot (Box and ampoule): 0280719
|
31 March 2022
|
20 December 2019
|
| View |
2019-12-17-0311
|
Tetanus Toxoid
|
Bio-TT
|
BR-663
|
280819
|
Packaging Lot (box and ampoule): 0280819
|
31 March 2022
|
20 December 2019
|
| View |
2020-01-15-0009
|
Live Attenuated Rotavirus Vaccine
|
Rotarix
|
BR-674
|
AROLC537A
|
Packaging Lot: Box & PFS - AROLC537AA
|
31 March 2022
|
20 January 2020
|
| View |
2020-01-15-0010
|
Live Attenuated Measles, Mumps and Rubella Vaccine
|
-
|
BR-885
|
0159W020
|
Packaging lot (box and vials): 0159W020; Diluent: 0679S1008 (ED: May 2024)
|
31 March 2022
|
17 January 2020
|
| View |
2020-05-15-0116
|
Inactivated Poliomyelitis Vaccine (Types 1, 2 and 3)
|
Imovax Polio
|
BR-929
|
T3C91
|
Packaging Lot: Box - T3C911V; Vial -T3C91
|
31 March 2022
|
18 May 2020
|
| View |
2020-05-15-0117
|
Inactivated Poliomyelitis Vaccine (Types 1, 2 and 3)
|
Imovax Polio
|
BR-929
|
T3D32
|
Packaging Lot: Box - T3D321V; Vial -T3D32
|
31 March 2022
|
18 May 2020
|
| View |
2020-05-15-0118
|
Inactivated Poliomyelitis Vaccine (Types 1, 2 and 3)
|
Imovax Polio
|
BR-929
|
T3D80
|
Packaging Lot: Box - T3D801V; Vial -T3D80
|
31 March 2022
|
18 May 2020
|
| View |
2020-05-29-0145
|
PURIFIED VERO CELL RABIES VACCINE
|
Abhayrab
|
BR-629
|
19URAB035
|
Packaging Lot (box & vial): 19URAB035; Diluent: SCSVBA1218, MD: 10/2018, ED: 09/2022; Syringe: 1906501, MD: 2019-06 ED: 2024-05
|
31 March 2022
|
01 June 2020
|
| View |
2021-05-27-0240
|
ISOPHANE INSULIN HUMAN, RECOMBINANT DNA
|
WOSULIN - N
|
BRP-036
|
DV10500
|
Packaging lot (Box & Vial): DV10500
|
31 March 2022
|
28 May 2021
|
| View |
2020-08-27-0227
|
Hepatitis B Vaccine (Recombinant DNA)
|
None
|
BR-589
|
0330L007A
|
Packaging Lot: Box & vials - 0330L007A
|
31 March 2023
|
28 August 2020
|
| View |
2020-08-27-0228
|
Hepatitis B Vaccine (Recombinant DNA)
|
None
|
BR-589
|
0330L006
|
Packaging Lot: Box & vials - 0330L006
|
31 March 2023
|
01 September 2020
|
| View |
2020-09-17-0232
|
Hepatitis B Vaccine (Recombinant DNA)
|
Revac-B+
|
BR-724
|
51B20004A
|
Packaging Lot (box & vial): 51B20004A
|
31 March 2023
|
21 September 2020
|
| View |
2020-09-17-0233
|
Hepatitis B Vaccine (Recombinant DNA)
|
Revac-B+
|
BR-724
|
51B20003A
|
Packaging Lot (box & vial): 51B20003A
|
31 March 2023
|
21 September 2020
|